XML 98 R45.htm IDEA: XBRL DOCUMENT v3.26.1
Commitments and Contingencies (Details) - USD ($)
$ in Thousands
1 Months Ended
Jan. 31, 2025
Apr. 08, 2016
Feb. 29, 2024
Commitments and Contingencies [Line Items]      
Other expenses     $ 26,000
License Agreements [Member]      
Commitments and Contingencies [Line Items]      
Issuance of shares 277,823 882,353  
License upfront fee paid   $ 70  
Percentage of patent net sales   3.50%  
Percentage royalty of net sales 1.75%    
Percentage of sublicensee’s net sales 1.75%    
Percentage of non-royalty consideration 7.50%    
Other expenses   $ 50  
Milestones for orphan indication $ 75    
Milestones for a non-orphan indication $ 650    
License Agreements [Member] | Food and Drug Administration [Member]      
Commitments and Contingencies [Line Items]      
Other expenses   $ 100